RxDoctor Payments Data

August Igo, PA

Physician Assistant · London, KYNPI 1699399949

Payments from drug & device makers

$1,073in general payments, 2019–2025

Across 71 payments — averaging $15.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$292
  • Novo Nordisk$266
  • Lilly USA, LLC$146
  • AstraZeneca$134
  • Merck$55
  • Amgen$53
  • plus $127 from 5 others

What the payments were for

  • Food & beverage$1,073100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,073 in reported general payments places this provider in the 65th percentile of 1,448 physician assistant providers in Kentucky.

See all physician assistant providers in Kentucky

Medicare billing

Part B allowed, 2024
$1,971
Medicare patients
36
Services billed
73

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin34$37,862
EliquisApixaban14$18,313
JanuviaSitagliptin Phosphate13$14,619
CreonLipase/Protease/Amylase13$10,337
Ondansetron Hcl12$7,949
Stiolto RespimatTiotropium Br/Olodaterol Hcl13$6,152
Levothyroxine Sodium79$2,131
Losartan Potassium93$972
Rosuvastatin Calcium120$875
Dilt-XrDiltiazem Hcl13$747
SynthroidLevothyroxine Sodium23$597
Atorvastatin Calcium70$577
Azelastine Hcl36$562
Pantoprazole Sodium35$374
Buspirone Hcl13$373

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$29$18,31314 claims
MerckJanuvia$55$14,61913 claims
AbbVieCreon, Synthroid$292$10,93436 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 1,448 physician assistant providers in Kentucky.

Other physician assistant in London

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →